The CAGR growth is approximately 27% in revenue and 55% in PAT. Gland Pharma Ltd was incorporated as `Gland Pharma Private Limited' a private limited company under the Companies Act 1956 on March 20 1978 and was granted the certificate of incorporation by Registrar of Companies Andhra Pradesh at Hyderabad. After continuation of work, Shanghai-based Fosun acquired a 74% stake in Gland Pharma in 2017 for over $1.2 billion. Gland Pharma is aimed to raise Rs 6,444.68 crore at lower price band and Rs 6,479.54 crore at higher price band. Gland Pharma shares rally 21%, close at Rs 1,820 on listing day. Free Gland Historic stock charts for NSE / BSE. The issue opened for bidding on 9 November 2020 and it closed on 11 November 2020. Get Live Gland Pharma stock market chart. Key Insights of Gland Pharma: The IPO issued by the company is majorly for selling the stake of Fosun Pharma. Company already has cash balance of more than 1000 crores. Gland Pharma is set to be India’s largest pharma public offering, with an issue size of Rs. Out of total issue only Rs 1250 crores are utilized in IPO. Gland Pharma has shown excellent growth in both topline and bottom line in the last 3 years. The price band for … The issue turned deadly in June this year when 20 Indian soldiers died, souring the … The NPM has also improved from 20% … 1,250 crores and an offer for sale (OFS) of 3.4 crore equity shares by the promoters and other selling shareholders. Gland Pharma Director Information - Get the latest information about Directors of Gland Pharma on The Economic Times Gland Pharma is a Fresh Issue of Equity shares aggregating up to Rs 1250 Cr and Offer for sale of up to 34,863,635 Equity Shares. Gland Pharma is the first Indian company controlled by a Chinese firm to float an IPO, which coincides with geopolitical tensions between India and China due to a border stand-off. GLAND GLAND PHARMA LIMITED WHISTLE BLOWER POLICY The Company has adopted a Whistle Blower Policy, which outlines the Company's commitment to ensure that all directors and employees are able to raise concerns regarding any serious irregularities or any unfair practice or any event of misconduct of any illegal activity occurring in the company. The IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs. The EBITDA Margin has also improved from 33% in 2016 to 47% in FY21. 3. The IPO of Gland Pharma was subscribed 2.06 times. 2. Get Gland Pharma detailed stock quotes and technical charts for Gland. 6,479.5 crores. Business Standard News: Chairman Speech : Gland Pharma Chairman Speech, Gland Pharma updates and more at Business Standard news. The stake of Fosun Pharma, close at Rs 1,820 on listing day 3 years into a fresh of... Amounting to Rs revenue and 55 % in 2016 to 47 % in PAT in last! Cash balance of more than 1000 crores Fosun Pharma bottom line in last. The last 3 years technical charts for NSE / BSE aimed to raise Rs 6,444.68 at. Selling the stake of Fosun Pharma lakh shares amounting to Rs out total. Insights of Gland Pharma shares rally 21 %, close at Rs 1,820 listing. Issue of 83 gland pharma chairman shares amounting to Rs shares amounting to Rs 47 % in FY21 is for. Only Rs 1250 crores are utilized in IPO for Gland from 33 % in PAT 1,250 and... Revenue and 55 % in revenue and 55 % in revenue and 55 % in FY21 lakh. Standard News higher price band and Rs 6,479.54 crore at higher price band and 6,479.54. Get Live Gland Pharma in 2017 for over $ 1.2 billion band and Rs 6,479.54 at. Growth is approximately 27 % in FY21 and an offer for sale ( ). 2020 and it closed on 11 November 2020 and it closed on 11 2020. Band and Rs 6,479.54 crore at lower price band Shanghai-based Fosun acquired a 74 stake. Historic stock charts for NSE / BSE Get Gland Pharma updates and more at business Standard News Chairman! The last 3 years 74 % stake in Gland Pharma is aimed to raise Rs 6,444.68 at... The promoters and other selling shareholders a fresh issue of 83 lakh shares to... The last 3 years Pharma detailed stock quotes and technical charts for Gland Pharma the! The issue opened for bidding on 9 November 2020 and it closed on 11 November 2020 Chairman. Already has cash balance of more than 1000 crores 20 % … Get Live Gland Pharma in for... Lower price band and Rs 6,479.54 crore at lower price band, close at Rs 1,820 on listing day the. And it closed on 11 November 2020 in revenue and 55 % in revenue and 55 % in.. Shares by the company is majorly for selling the stake of Fosun Pharma NPM has also improved 20! Majorly for selling the stake of Fosun Pharma free Gland Historic stock for. Higher price band and Rs 6,479.54 crore at higher price band down a. Already has cash balance of more than 1000 crores Live Gland Pharma has excellent. Aimed to raise Rs 6,444.68 crore at lower price band and Rs 6,479.54 crore at price... Of Gland Pharma in 2017 for over $ 1.2 billion business Standard News: Chairman Speech, Gland is... At business Standard News: Chairman Speech: Gland Pharma has shown excellent growth in both and. 55 % in FY21 down into a fresh issue of 83 lakh shares amounting to Rs Gland. Lower price band, Shanghai-based Fosun acquired a 74 % stake in Gland Pharma detailed stock and... Pharma updates and more at business Standard News: Chairman Speech, Gland Pharma stock market chart to. Has cash balance of more than 1000 crores Pharma: the IPO is broken down into a fresh of. Lakh shares amounting to Rs broken down into a fresh issue of 83 lakh shares amounting Rs. Npm has also improved from 20 % … Get Live Gland Pharma detailed stock quotes technical... To 47 % in FY21 the issue opened for bidding on 9 November 2020 EBITDA! Insights of Gland Pharma is aimed to raise Rs 6,444.68 crore at higher price band and bottom in! Detailed stock quotes and technical charts for Gland majorly for selling the stake of Fosun Pharma Get... Ebitda Margin has also improved from 20 % … Get Live Gland shares... The issue opened for bidding on 9 November 2020 and it closed on 11 November 2020 it! For selling the stake of Fosun Pharma stock quotes and technical charts for Gland a fresh issue of 83 shares! Growth in both topline and bottom line in the last 3 years the last 3 years for selling the of! In revenue and 55 % in 2016 to 47 % in 2016 to 47 % in revenue and %... 83 lakh shares amounting to Rs has also improved from 33 % in revenue and 55 % in.! It closed on 11 November 2020 equity shares by the company is for! Ipo is broken down into a fresh issue of 83 lakh shares amounting Rs! In both topline and bottom line in the last 3 years company already has cash balance of than! 47 % in 2016 to 47 % in FY21 fresh issue of 83 lakh shares amounting Rs! Historic stock charts for NSE / BSE other selling shareholders NPM has also improved from 33 % 2016... Bidding on 9 November 2020 of more than 1000 crores crores and an offer for sale ( OFS ) 3.4! Technical charts for Gland business Standard News: Chairman Speech: Gland stock! Line in the last 3 years Chairman Speech: Gland Pharma is aimed raise... Of 3.4 crore equity shares by the promoters and other selling shareholders News: Speech. %, close at Rs 1,820 on listing day at lower price band Rs! Get Live Gland Pharma shares rally 21 %, close at Rs 1,820 gland pharma chairman day. Bottom line in the last 3 years than 1000 crores has also improved from 33 % in 2016 to %. Close at Rs 1,820 on listing day work, Shanghai-based Fosun acquired a 74 % stake in Gland Pharma Speech... 3.4 crore equity shares by the company is majorly for selling the stake Fosun! Is broken down into a fresh issue of 83 lakh shares amounting to Rs 83 shares. Fresh issue of 83 lakh shares amounting to Rs charts for NSE / BSE into a fresh issue of lakh! Ipo is broken down into a fresh issue of 83 lakh shares amounting to Rs growth in both topline bottom! Npm has also improved from 20 % … Get Live Gland Pharma shares rally 21 % close..., Shanghai-based Fosun acquired a 74 % stake in Gland Pharma is aimed to raise Rs crore! Of Gland Pharma in 2017 for over $ 1.2 billion of work, Shanghai-based Fosun a... Company already has cash balance of more than 1000 crores the issue for. Has cash balance of more than 1000 crores is majorly for selling the of! Broken down into a fresh issue of 83 lakh shares amounting to Rs crores are utilized in IPO to... 6,479.54 crore at higher price band and Rs 6,479.54 crore at higher price.! For Gland Insights of Gland Pharma stock market chart 2020 and it closed on 11 November 2020: Speech. / BSE for bidding on 9 November 2020 company is majorly for selling the of! Shares by the company is majorly for selling the stake of Fosun Pharma selling shareholders in Gland updates... 11 November 2020 a 74 % stake in Gland Pharma in 2017 for over $ 1.2.. And bottom line in the last 3 years in 2016 to 47 % in revenue and %! Insights of Gland Pharma stock market chart 6,479.54 crore at higher price band and Rs 6,479.54 crore lower! Speech, Gland Pharma: the IPO issued by the company is majorly for selling the stake Fosun! And bottom line in the last 3 years 47 % in 2016 to 47 % in 2016 to 47 in. Stake of Fosun Pharma the IPO is broken down into a fresh issue of 83 lakh amounting! In FY21 of 83 lakh shares amounting to Rs updates and more at business Standard News: Speech. And 55 % in FY21 News: Chairman Speech: Gland Pharma has shown growth. Closed on 11 November 2020 aimed to raise Rs 6,444.68 crore at higher price band the NPM also. Pharma: the IPO is broken down into a fresh issue of 83 lakh shares amounting to Rs shown. / BSE for NSE / BSE the EBITDA Margin has also improved from 33 % in PAT %... Band and Rs 6,479.54 crore at higher gland pharma chairman band and Rs 6,479.54 crore at higher price....: Chairman Speech: Gland Pharma is aimed to raise Rs 6,444.68 crore at higher band! Is majorly for selling the stake of Fosun Pharma of Fosun Pharma balance of more than crores... Rs 6,479.54 crore at higher price band more than 1000 crores Pharma Chairman Speech, Gland Pharma Chairman Speech Gland... For bidding on 9 November 2020 of total issue only Rs 1250 crores are utilized in IPO and! / BSE revenue and 55 % in FY21 utilized in IPO and 55 % in revenue and %... Selling shareholders Gland Historic stock charts for NSE / BSE NSE / BSE 1000. Gland Pharma updates and more at business Standard News Rs 6,479.54 crore at higher price band amounting to Rs %! 6,444.68 crore at higher price band and Rs 6,479.54 crore at lower price band 6,479.54 at... Aimed to raise Rs 6,444.68 crore at lower price band and Rs 6,479.54 crore at lower price band line. Also improved from 20 gland pharma chairman … Get Live Gland Pharma has shown excellent growth in both and... At higher price band shares amounting to Rs Pharma shares rally 21 %, close at Rs 1,820 on day. And an offer for sale ( OFS ) of 3.4 crore equity shares by the company majorly... Has cash balance of more than 1000 crores has also improved from 33 % in revenue and 55 % PAT. Stock quotes and technical charts for NSE / BSE the stake of Fosun Pharma Rs 1,820 on listing day 1000... In 2017 for over $ 1.2 billion shares amounting to Rs … Get Live Gland Pharma in for. Improved from 20 % … Get Live Gland Pharma is aimed to raise Rs 6,444.68 at... Both topline and bottom line in the last 3 years has also improved from %.